Sustained, high-level activation of ER signaling sensors (PERK, ATF6, and IRE1α) was detectable in these cancer tissues, which may promote tumor cell proliferation, migration, invasion, vascularization, drug resistance, and immunosuppression (11). The gene discussed is EIF2AK3; the disease is cancer.